Suppr超能文献

肺类器官:最新进展及其未来展望的系统综述。

Lung Organoids: Systematic Review of Recent Advancements and its Future Perspectives.

机构信息

Centre for Drug Discovery and Development, Sathyabama Institute of Science and Technology, Chennai, Tamil Nadu, 600119, India.

Medway Hospitals, No 2/26, 1st Main Road, Kodambakkam, Chennai, Tamil Nadu, 600024, India.

出版信息

Tissue Eng Regen Med. 2024 Jul;21(5):653-671. doi: 10.1007/s13770-024-00628-2. Epub 2024 Mar 11.

Abstract

Organoids are essentially an in vitro (lab-grown) three-dimensional tissue culture system model that meticulously replicates the structure and physiology of human organs. A few of the present applications of organoids are in the basic biological research area, molecular medicine and pharmaceutical drug testing. Organoids are crucial in connecting the gap between animal models and human clinical trials during the drug discovery process, which significantly lowers the time duration and cost associated with each stage of testing. Likewise, they can be used to understand cell-to-cell interactions, a crucial aspect of tissue biology and regeneration, and to model disease pathogenesis at various stages of the disease. Lung organoids can be utilized to explore numerous pathophysiological activities of a lung since they share similarities with its function. Researchers have been trying to recreate the complex nature of the lung by developing various "Lung organoids" models.This article is a systematic review of various developments of lung organoids and their potential progenitors. It also covers the in-depth applications of lung organoids for the advancement of translational research. The review discusses the methodologies to establish different types of lung organoids for studying the regenerative capability of the respiratory system and comprehending various respiratory diseases.Respiratory diseases are among the most common worldwide, and the growing burden must be addressed instantaneously. Lung organoids along with diverse bio-engineering tools and technologies will serve as a novel model for studying the pathophysiology of various respiratory diseases and for drug screening purposes.

摘要

类器官本质上是一种体外(实验室培养)的三维组织培养系统模型,能够精确复制人体器官的结构和生理学特性。目前类器官的一些应用领域包括基础生物学研究、分子医学和药物测试。在药物发现过程中,类器官在连接动物模型和人体临床试验之间的空白方面发挥着至关重要的作用,显著降低了每个测试阶段的时间和成本。同样,它们可以用于了解细胞间的相互作用,这是组织生物学和再生的关键方面,并在疾病的各个阶段模拟疾病的发病机制。肺类器官可以用于探索肺的许多病理生理活动,因为它们与肺的功能相似。研究人员一直在通过开发各种“肺类器官”模型来尝试重现肺的复杂性质。本文对肺类器官及其潜在前体细胞的各种发展进行了系统综述。它还涵盖了肺类器官在推进转化研究方面的深入应用。该综述讨论了建立不同类型肺类器官的方法,用于研究呼吸系统的再生能力和理解各种呼吸道疾病。呼吸道疾病是全球最常见的疾病之一,必须立即解决日益增长的负担。肺类器官以及各种生物工程工具和技术将成为研究各种呼吸道疾病的病理生理学和药物筛选目的的新型模型。

相似文献

1
Lung Organoids: Systematic Review of Recent Advancements and its Future Perspectives.
Tissue Eng Regen Med. 2024 Jul;21(5):653-671. doi: 10.1007/s13770-024-00628-2. Epub 2024 Mar 11.
3
The Black Book of Psychotropic Dosing and Monitoring.
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
5
Management of urinary stones by experts in stone disease (ESD 2025).
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
8
Anterior Approach Total Ankle Arthroplasty with Patient-Specific Cut Guides.
JBJS Essent Surg Tech. 2025 Aug 15;15(3). doi: 10.2106/JBJS.ST.23.00027. eCollection 2025 Jul-Sep.
9
MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.
Alzheimers Dement. 2021 Apr;17(4):704-715. doi: 10.1002/alz.12215. Epub 2021 Jan 21.

引用本文的文献

1
Advancing lung organoids toward clinical applications: a global perspective on research focus and future directions.
Front Med (Lausanne). 2025 Jul 16;12:1611304. doi: 10.3389/fmed.2025.1611304. eCollection 2025.
2
Establishment of Human Lung Cancer Organoids Using Small Biopsy and Surgical Tissues.
Cancers (Basel). 2025 Jul 10;17(14):2291. doi: 10.3390/cancers17142291.
3
Experimental dissection of tuberculosis protective immunity: a human perspective.
Front Cell Infect Microbiol. 2025 Jun 30;15:1595076. doi: 10.3389/fcimb.2025.1595076. eCollection 2025.
4
Epitope-Based Vaccines: The Next Generation of Promising Vaccines Against Bacterial Infection.
Vaccines (Basel). 2025 Feb 27;13(3):248. doi: 10.3390/vaccines13030248.
5
Exploring organoid and assembloid technologies: a focus on retina and brain.
Expert Rev Mol Med. 2025 Mar 27;27:e14. doi: 10.1017/erm.2025.9.
6
Natural ingredients in the regulation of abnormal lipid peroxidation: a potential therapy for pulmonary diseases.
Front Pharmacol. 2024 Dec 20;15:1507194. doi: 10.3389/fphar.2024.1507194. eCollection 2024.

本文引用的文献

1
Lung extracellular matrix modulates KRT5 basal cell activity in pulmonary fibrosis.
Nat Commun. 2023 Sep 27;14(1):6039. doi: 10.1038/s41467-023-41621-y.
2
The pro-inflammatory response to influenza A virus infection is fueled by endothelial cells.
Life Sci Alliance. 2023 Apr 18;6(7). doi: 10.26508/lsa.202201837. Print 2023 Jul.
3
Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study.
Cell Rep Med. 2023 Feb 21;4(2):100911. doi: 10.1016/j.xcrm.2022.100911. Epub 2023 Jan 18.
5
Organoid modeling of human fetal lung alveolar development reveals mechanisms of cell fate patterning and neonatal respiratory disease.
Cell Stem Cell. 2023 Jan 5;30(1):20-37.e9. doi: 10.1016/j.stem.2022.11.013. Epub 2022 Dec 8.
6
Lung organoids: current strategies for generation and transplantation.
Cell Tissue Res. 2022 Dec;390(3):317-333. doi: 10.1007/s00441-022-03686-x. Epub 2022 Sep 30.
9
Patient-derived micro-organospheres enable clinical precision oncology.
Cell Stem Cell. 2022 Jun 2;29(6):905-917.e6. doi: 10.1016/j.stem.2022.04.006. Epub 2022 May 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验